Verbal memory in schizophrenia: sex differences over repeated assessments

https://doi.org/10.1016/S0920-9964(02)00285-2Get rights and content

Abstract

There is conflicting evidence regarding the presence and direction of gender differences in verbal memory capacity in schizophrenia. We examined gender differences in verbal memory performance in schizophrenia and their interactions with repeated assessments and psychiatric symptoms. California Verbal Learning Test (CVLT) data were collected from 28 outpatients diagnosed with schizophrenia. The CVLT was administered on five occasions, 3 months apart. CVLT data were examined using repeated measures analyses, using maximum likelihood estimates, with Brief Psychiatric Rating Scale (BPRS) scores at assessments 1–5 as a time-varying covariate. There were significant main effects of time and gender, with scores improving over time, and women performing better than men. There was also a significant time by gender interaction. The BPRS covariate effect was not significant. Results are discussed in terms of implications for gender-informed approaches to rehabilitation treatments.

Introduction

Verbal memory and learning deficits have been well documented in schizophrenia Aleman et al., 1999, Chan et al., 2000, Fossati et al., 1999, Nathaniel-James et al., 1996, Saykin et al., 1991. Whereas in nonpsychiatrically ill samples, women tend to perform better than men on measures of verbal memory Bleecker et al., 1988, Kramer et al., 1988, this gender effect is not as pronounced in studies of individuals with schizophrenia. Some studies found no significant gender effects Goldberg et al., 1995, Ragland et al., 1999, while some have suggested that women perform better than men Albus et al., 1997, Goldstein et al., 1998. One study suggested better verbal memory function for men (Lewine et al., 1996). In trying to reconcile these results, Goldstein et al. (1998) suggested that the varied findings are due to sampling differences. Specifically, the majority of males with schizophrenia, as compared to females with schizophrenia, tend to have an earlier age of onset, poorer premorbid history, poorer course, poorer response to neuroleptics, longer hospital stays, and poorer outcomes Angermeyer et al., 1990, Childers and Harding, 1990, Goldstein, 1988, Goldstein and Tsuang, 1990, McGlashan and Bardenstein, 1990, Seeman, 1986. Goldstein et al. (1998) suggested that these course factors are associated with poorer neuropsychological performance and early developmental deficits and not gender per se. In support of this idea, Goldstein et al. (1998) noted that studies which sample only the most chronic patients (and thereby include females who are more impaired than the modal female with schizophrenia) tend to be the ones that do not show a gender difference on neuropsychological measures.

The verbal memory data reported above come from single assessments with schizophrenic patients. While these data indicate single-trial performance deficits, they do not provide information about the variability or permanence of these deficits. Schizophrenia is a syndrome characterized by several phases (e.g., onset/relapse, stabilization, remission) and therefore by change over time. Changes over time in factors such as symptoms are typical, and can be considered critical indicators of clinical improvement or deterioration. A number of aspects of cognitive functioning is also known to change with clinical state in schizophrenia Neuchterlein et al., 1992, Silverstein et al., 1996; however, verbal memory has not been extensively studied in this regard. This issue is important because studies have indicated that level of verbal memory impairment is one of the strongest predictors of rehabilitative treatment outcome and overall level of functioning Green, 1996, Smith et al., 1999b.

Evidence indicates that practice effects exist for tests of memory. For example, Goldberg et al. (1989) reported a significant increase in Selective Reminding Test scores over immediate repeated trials in a sample of controls and patients with schizophrenia. Similarly, in a sample of HIV-positive and “at risk” volunteers, McCaffrey et al. (1995) reported a practice effect on an abbreviated neuropsychological battery (which included memory measures) at a 7–10-day retest interval. Hawkins and Wexler (1999) examined California Verbal Learning Test (CVLT) indices in a sample of 20 patients with schizophrenia, and also reported a significant practice effect. As part of a larger intervention study where patients practiced different cognitive and sensory-motor tasks, CVLT assessments were examined at baseline, 10 weeks post-baseline, and 14 weeks post-baseline. Practice effect sizes (d) across the three assessment times varied between 0.28 (change between second and third testing) and 0.81 (change between first and third testing), and there were significant differences between trials 1 and 5 total between the baseline and week 10, as well as week 10 and week 14 assessments.

The current investigation extends the Hawkins and Wexler (1999) study by increasing the number of repeated assessments and extending the length of follow-up. The purpose of the current investigation was to determine whether performance of patients with schizophrenia on a memory measure would improve over repeated assessments extended over a 1-year period. Study of the repeated administration effect in schizophrenia is quite important, as it provides information on patients' ability to benefit from information presented earlier, and as such, represents a type of learning. Although repeated administration effects are likely the most conservative indicators of the ability to learn, they nevertheless provide invaluable data about the potential remediation of cognitive deficits in schizophrenia. Within the context of recent data suggesting sex differences in neuropsychological performance, we also thought it would be informative to examine the effect of gender on repeated performance. Additionally, we wished to examine whether changes in performance were associated with particular learning strategies.

Section snippets

Method

Data presented here are part of a 2-year longitudinal study examining recovery processes in schizophrenia and schizoaffective disorder (Smith et al., 1999a). In the parent study, neurocognitive, insight, functioning, and symptom measures were administered to patients who had been discharged from an inpatient unit and subsequently enrolled in an outpatient clinic. Initial assessments were conducted within 30 days of discharge from the inpatient unit. Subsequently, assessments were repeated every

Verbal learning

For verbal learning (sum of trials 1–5), there was a main effect of assessment time [Wald χ2(4)=28.54, p<0.0001] and gender [Wald χ2(1)=8.61, p<0.005], with scores improving over time, and women performing better than men (see Fig. 1). There was also a gender by assessment time interaction [Wald χ2(4)=14.74, p<0.01]. The effects of the two covariates, BPRS score and age, were not significant [BPRS: χ2(1)=1.22, p=0.27; age: χ2(1)=0.14, p=0.71]. Analysis of orthogonal components indicated a

Discussion

Taken as a group, patients with schizophrenia consistently improved their CVLT performance over the repeated assessments. This learning or practice effect, however, was different for males and females. There were also gender differences in the types of organizational strategies used by the patients.

Results of the current investigation support earlier research indicating a verbal memory deficit in schizophrenia Aleman et al., 1999, Chan et al., 2000, Fossati et al., 1999, Nathaniel-James et al.,

References (44)

  • M.L. Bleecker et al.

    Age-related sex differences in verbal memory

    J. Clin. Psychol.

    (1988)
  • M. Budoff

    Measures for assessing learning potential

  • S.E. Childers et al.

    Gender, premorbid social functioning, and long-term outcome in DSM-III schizophrenia

    Schizophr. Bull.

    (1990)
  • D.C. Delis et al.

    California Verbal Learning Test Research Edition Manual (Version 1)

    (1987)
  • W.J. Dixon et al.

    ANOVA and Regression with BMDP 5V

    (1992)
  • M.B. First et al.

    Structured Clinical Interview for DSM-IV Axis I Disorders—Patient Edition (SCID-I/P, Version 2.0)

    (1996)
  • M.R. Foy et al.

    Estrogen and neural plasticity

    Curr. Dir. Psychol. Sci.

    (2000)
  • T.E. Goldberg et al.

    Lack of sex differences in the neuropsychological performance of patients with schizophrenia

    Am. J. Psychiatry

    (1995)
  • J.M. Goldstein

    Gender differences in the course of schizophrenia

    Am. J. Psychiatry

    (1988)
  • J.M. Goldstein et al.

    Gender and schizophrenia: an introduction and synthesis of findings

    Schizophr. Bull.

    (1990)
  • J.M. Goldstein et al.

    Are there sex differences in neuropsychological functions among patients with schizophrenia?

    Am. J. Psychiatry

    (1998)
  • Cited by (26)

    • Gender differences of neurocognitive functioning in patients with first-episode schizophrenia in China

      2019, Comprehensive Psychiatry
      Citation Excerpt :

      These studies have shown that gender differences are present in the prodromal, acute, and chronic stages of schizophrenia [19–21]. Although previous studies have produced equivocal findings [22–24], evidence indicates that while males are superior to females in visuospatial functioning, females perform better in memory, verbal abilities, and executive functioning [9,18,25]. The majority of studies in this field have been conducted with heterogeneous samples of institutionalized and chronically ill patients.

    • Sex and Diagnosis-Specific Associations between DNA Methylation of the Oxytocin Receptor Gene with Emotion Processing and Temporal-Limbic and Prefrontal Brain Volumes in Psychotic Disorders

      2016, Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
      Citation Excerpt :

      Our sex-specific findings highlight the complex pathophysiology of schizophrenia, with female-specific epigenetic factors in OT pathways contributing to and perhaps amplifying social cognition deficits in this disorder. Our findings complement other data highlighting the importance of sex differences in schizophrenia that have been reported in cognition (72–76), clinical symptoms and disease course (77–82), and treatment response (76,80,83). The factors causing more severe illness in males or that preserve social cognition in female schizophrenia patients remain to be identified.

    • Gender differences in cognitive deficits in schizophrenia with and without diabetes

      2015, Comprehensive Psychiatry
      Citation Excerpt :

      Currently, we are not sure exactly why males have a poorer glycemic control than females in schizophrenia with diabetes. However, both the current and other previous studies have found that males have worse negative symptoms, response to antipsychotics, and cognitive deficits than females with schizophrenia [6–9,11–13]. This may affect more daily life and self-medical protection awareness for male individuals and lead to their poorer glycemic control.

    • Effects of sex, menstrual cycle phase, and endogenous hormones on cognition in schizophrenia

      2015, Schizophrenia Research
      Citation Excerpt :

      We sought to determine whether those sex differences are preserved in schizophrenia, change across the menstrual cycle in schizophrenia, and related to physiological levels of sex hormones and oxytocin. Consistent with findings from healthy individuals (Halpern, 1986; Kimura and Hampson, 1993), and in schizophrenia (Gur et al., 2001; Fiszdon et al., 2003; Sota and Heinrichs, 2003; Halari et al., 2006; Rubin et al., 2008), our findings suggest that we were justified in grouping tests according to “female-dominant” and “male-dominant” abilities and that this pattern of sex-related cognitive abilities is preserved in individuals with schizophrenia. Contrary to prediction, cognitive performance was unrelated to variations in sex steroid hormones across the menstrual cycle in women with or without schizophrenia.

    • Gender difference in association of cognition with BDNF in chronic schizophrenia

      2014, Psychoneuroendocrinology
      Citation Excerpt :

      However, gender differences in these cognitive deficits among SZ patients have produced equivocal findings. For example, some studies indicate men to be more impaired than women (Goldstein et al., 1998; Fiszdon et al., 2003) whereas others report the opposite (Lewine et al., 1996; Brébion et al., 2004) or no difference (Gur et al., 2001; Halari et al., 2006). Moreover, the pathophysiological mechanisms underlying these gender differences in cognitive deficits of SZ are still unclear and have previously received little systematic study.

    View all citing articles on Scopus
    View full text